Full-Time

Organ Health Specialist

Thoracic

Posted on 12/31/2024

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$180k - $205kAnnually

Senior

Minneapolis, MN, USA

Territory includes the Midwest.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Sales
Requirements
  • Bachelor's Degree or equivalent educational background.
  • A minimum of 6 years of progressive sales experience, ideally within the diagnostic or lab-developed tests industry.
  • Knowledge of academic medical systems related to transplant, heart and Lung or specialty medicine.
  • Established relationships with KOLs in transplant, or specialty medicine.
  • Background in medicine, biological sciences, or genetics is preferred.
  • Ability to work effectively with diverse teams to define and implement strategic plans.
  • Comfortable thriving in a startup environment, demonstrating initiative, self-motivation, and time management skills.
  • A driven professional with a competitive mindset and a commitment to achieving and exceeding results.
  • Strong problem-solving abilities, with a creative and independent approach to overcoming challenges.
  • Excellent interpersonal, presentation, and communication skills.
Responsibilities
  • Demonstrating a proven track record of closing sales, fostering client relationships, and driving sustainable growth.
  • Leveraging your expertise to successfully launch products in the transplant market, contributing to brand development and market expansion.
  • Becoming a local expert on Natera’s technology and services, representing our company at the highest levels.
  • Developing and executing local business plans tailored to meet sales objectives and optimize available resources.

Natera focuses on genetic testing and diagnostics, providing advanced solutions for cancer patients, transplant patients, and individuals assessing hereditary health risks. Their main technology, cell-free DNA (cfDNA) testing, analyzes DNA fragments in the blood to detect minimal traces of cancer and monitor organ health. Natera stands out by offering specialized tests and genetic counseling services directly to healthcare providers and patients, generating revenue through testing kits and services often covered by insurance. The company's goal is to improve patient care through precise genetic insights and early detection of health issues.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's customized genetic tests.

What critics are saying

  • Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE